PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells

As a therapeutic approach, epigenetic modifiers have the potential to enhance the efficacy of chemotherapeutic agents. Protein arginine methyltransferase 5 (PRMT5), highly expressed in lung adenocarcinoma, was identified to be involved in tumorigenesis. In the current study, we examined the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajbouj, Khuloud, Ramakrishnan, Rakhee K., Saber-Ayad, Maha, Omar, Hany A., Saheb Sharif-Askari, Narjes, Shafarin, Jasmin, Elmoselhi, Adel B., Ihmaid, Ahmed, AlHaj Ali, Suhib, Alalool, Abdulla, Abdullah, Reem, Hamid, Qutayba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201369/
https://www.ncbi.nlm.nih.gov/pubmed/34200178
http://dx.doi.org/10.3390/ijms22116131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201369/
https://www.ncbi.nlm.nih.gov/pubmed/34200178
http://dx.doi.org/10.3390/ijms22116131

Ejemplares similares